[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=47a32b8e320256d981d84e80b60d3c56d21e5d7bf1f515f17827781836502209",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747067760,
      "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 134405161,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=47a32b8e320256d981d84e80b60d3c56d21e5d7bf1f515f17827781836502209"
    }
  },
  {
    "ts": null,
    "headline": "Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years",
    "summary": "Vertex Pharmaceuticals is diversifying its already strong lineup of medicines.  Axsome Therapeutics has multiple clinical and regulatory catalysts on the way.  Two excellent candidates are Vertex Pharmaceuticals (NASDAQ: VRTX) and Axsome Therapeutics (NASDAQ: AXSM).",
    "url": "https://finnhub.io/api/news?id=f00c4cc3a0fc3e67e9421cf3cbb7584f6527921ac0fe945ca4034dd0b1f4e271",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747048080,
      "headline": "Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years",
      "id": 134379473,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex Pharmaceuticals is diversifying its already strong lineup of medicines.  Axsome Therapeutics has multiple clinical and regulatory catalysts on the way.  Two excellent candidates are Vertex Pharmaceuticals (NASDAQ: VRTX) and Axsome Therapeutics (NASDAQ: AXSM).",
      "url": "https://finnhub.io/api/news?id=f00c4cc3a0fc3e67e9421cf3cbb7584f6527921ac0fe945ca4034dd0b1f4e271"
    }
  },
  {
    "ts": null,
    "headline": "Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?",
    "summary": "The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline.",
    "url": "https://finnhub.io/api/news?id=2c4534dc2a057cbe55a60db005bc7eb80f97dc28712a90bb82e6eaaf30c80361",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747045080,
      "headline": "Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?",
      "id": 134379474,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline.",
      "url": "https://finnhub.io/api/news?id=2c4534dc2a057cbe55a60db005bc7eb80f97dc28712a90bb82e6eaaf30c80361"
    }
  }
]